Swiss HLG Conference on May 25–27

The Avance team is attending the Swiss HLG Conference on May 25–27, in Montreux, Switzerland representing Royalty Monetization, the educational platform for this form of alternative financing (https://lnkd.in/dxW8hi2D) and proud sponsor of Swiss HLG.We are looking forward to 2 days with the industry's brightest minds to discuss the current state of affairs in pharma deal making and financing.

Lastest posts

View all posts->
June
02
-
,
2025
- release at
CET
US

Theravance hands off the last of its Trelegy royalties to GSK for $225M

Theravance hands off the last of its Trelegy royalties to GSK for $225M

After years of picking up royalties on GSK’s asthma and COPD inhaler Trelegy, Theravance Biopharma is opting to sell its remaining financial interest to GSK in exchange for a cash reward of $225 million.
May
25
-
27
,
2025
- release at
CET
Switzerland

Swiss HLG Conference on May 25–27

Swiss HLG Conference on May 25–27

The Avance team is at Swiss HLG in Montreux, proudly representing Royalty Monetization. Excited for key insights on pharma deal-making and financing.
-
,
- release at
CET

From Lab to Liquidity: Royalty and Milestone Monetization for Universities and Inventors

From Lab to Liquidity: Royalty and Milestone Monetization for Universities and Inventors

Universities, research institutes, and academic centers are powerhouses of innovation in pharmaceuticals and biotechnology, developing novel technologies, drug candidates, and intellectual property (IP) that promise to transform healthcare.
View all posts->

Request a free calculation of your royalties

Fill in a form with key details and we’ll get back to you with calculation

Request calculation